Skip to content

Patients › Elbow

ਕੋਹੜੀ ਦਾ ਓਸਟੀਓਆਰਥਰਾਈਟਿਸ

Osteoarthritis of the elbow — primary and post-traumatic, conservative and surgical options.

Updated Aug 2026
ਇੱਕ ਹੱਥ ਨਾਲ ਖਿੱਚੀ ਗਈ ਚਿੱਤਰ ਜਿਸ ਵਿੱਚ ਇੱਕ ਬਿਨਾਂ ਚਿਹਰੇ ਵਾਲੇ ਵੱਡੇ ਉਮਰ ਦੇ ਵਿਅਕਤੀ ਨੂੰ ਇੱਕ ਸਖ਼ਤ ਅਤੇ ਦਾਦੀ ਭਰੇ ਕੋਹਣੀ ਨੂੰ ਪੂਰੀ ਤਰ੍ਹਾਂ ਸਿੱਧਾ ਕਰਨ ਵਿੱਚ ਮੁਸ਼ਕਲ ਹੋ ਰਹੀ ਹੈ।
ਬਾਹਰੀ ਐਕਸ-ਰੇ ਜਿਸ ਵਿੱਚ ਕੋਹੜੀ ਦੇ ਸੰਯੁਕਤ ਸਥਾਨ ਵਿੱਚ ਆਸਟੀਓਆਰਥਰਾਈਟਸ ਦਿਖਾਈ ਦੇ ਰਿਹਾ ਹੈ — ਸੰਯੁਕਤ ਸਥਾਨ ਦੀ ਸੰਗੁਚਨ ਅਤੇ ਹੱਡੀ ਦੇ ਚੰਗੇ ਬਣਨ ਦੀ ਸਥਿਤੀ। Kieran Hirpara 4.0

ਇਹ ਪੰਨਾ ਮਸ਼ੀਨ ਦੁਆਰਾ ਅਨੁਵਾਦ ਕੀਤਾ ਗਿਆ ਹੈ ਅਤੇ ਹਾਲੇ ਤੱਕ ਕਿਸੇ ਡਾਕਟਰ ਦੁਆਰਾ ਜਾਂਚਿਆ ਨਹੀਂ ਗਿਆ। ਅੰਗਰੇਜ਼ੀ ਸੰਸਕਰਣ ਹੀ ਅਧਿਕਾਰਤ ਹੈ।

ਤੁਸੀਂ ਕੀ ਮਹਿਸੂਸ ਕਰ ਰਹੇ ਹੋ

ਤੁਸੀਂ ਆਪਣੇ ਕੋਹਣੀ ਵਿੱਚ ਦਰਦ ਮਹਿਸੂਸ ਕਰ ਸਕਦੇ ਹੋ, ਜੋ ਜੋੜ ਦੇ ਅੰਦਰੂਨੀ ਹਿੱਸੇ ਵਿੱਚ ਡੂੰਘਾ ਲੱਗਦਾ ਹੈ। ਇਹ ਘਸਾਅ-ਪਹਿਣਾਅ ਥਲਾਈਟਿਸ (wear-and-tear arthritis) ਅਕਸਰ ਵਿਚਕਾਰਲੀ ਉਮਰ ਵਿੱਚ ਸ਼ੁਰੂ ਹੁੰਦੀ ਹੈ ਅਤੇ ਭਾਰੀ ਮੈਨੁਅਲ ਕੰਮ ਕਰਨ ਵਾਲੇ ਮਰਦਾਂ ਵਿੱਚ ਵਧੇਰੇ ਆਮ ਹੈ। ਤੁਸੀਂ ਸਖ਼ਤੀ (stiffness) ਵੀ ਮਹਿਸੂਸ ਕਰ ਸਕਦੇ ਹੋ, ਖਾਸ ਕਰਕੇ ਜਦੋਂ ਤੁਸੀਂ ਸਵੇਰ ਨੂੰ ਪਹਿਲਾਂ ਜਾਗਦੇ ਹੋ। ਦਰਦ ਤੁਹਾਡੇ ਹੱਥ ਦੀ ਵਰਤੋਂ ਕਰਨ ਤੋਂ ਬਾਅਦ ਤੇਜ਼ ਹੋ ਸਕਦਾ ਹੈ, ਜਾਂ ਇੱਥੋਂ ਤੱਕ ਕਿ ਰਾਤ ਨੂੰ ਵੀ ਜੇਕਰ ਤੁਸੀਂ ਉਸ ਪਾਸੇ ਸੌਂਦੇ ਹੋ।

ਤੁਹਾਡੀ ਕੋਹਣੀ ਪਹਿਲਾਂ ਵਾਂਗ ਆਜ਼ਾਦੀ ਨਾਲ ਨਹੀਂ ਘੁੰਮ ਸਕਦੀ। ਤੁਹਾਨੂੰ ਆਪਣਾ ਹੱਥ ਪੂਰੀ ਤਰ੍ਹਾਂ ਸਿੱਧਾ ਕਰਨ ਜਾਂ ਪੂਰੀ ਤਰ੍ਹਾਂ ਮੋੜਨ ਵਿੱਚ ਮੁਸ਼ਕਲ ਆ ਸਕਦੀ ਹੈ। ਰੋਜ਼ਾਨਾ ਸਰਲ ਕੰਮ ਮੁਸ਼ਕਲ ਹੋ ਸਕਦੇ ਹਨ। ਪਿੱਛੇ ਜਾ ਕੇ ਬ੍ਰਾ ਬੰਨ੍ਹਣ ਜਾਂ ਸ਼ਰਟ ਨੂੰ ਅੰਦਰ ਧਕਾਉਣਾ ਅਜੀਬ ਜਾਂ ਦਰਦਨਾਕ ਲੱਗ ਸਕਦਾ ਹੈ। ਤੁਸੀਂ ਕੋਹਣੀ ਨੂੰ ਘੁਮਾਉਣ ਸਮੇਂ ਘਸਣ ਦੀ ਅਹਿਸਾਸ ਜਾਂ ਕਲਿੱਕ (clicking) ਆਵਾਜ਼ ਸੁਣਨ ਵੀ ਦੇਖ ਸਕਦੇ ਹੋ। ਕੁਝ ਮਾਮਲਿਆਂ ਵਿੱਚ, ਤੁਸੀਂ ਆਪਣੇ ਅਨਾਮਿਕਾ ਅਤੇ ਛੋਟੀ ਉਂਗਲੀ ਵਿੱਚ ਸੁੰਨਤਾ ਜਾਂ ਚੁੰਬਕੀ ਭਾਵਨਾ (tingling or numbness) ਮਹਿਸੂਸ ਕਰ ਸਕਦੇ ਹੋ, ਜੋ ਇਹ ਸੰਕੇਤ ਦਿੰਦਾ ਹੈ ਕਿ ਤੁਹਾਡੇ ਜੋੜ ਵਿੱਚ ਤਬਦੀਲੀਆਂ ਕਾਰਨ ਅਲਨਰ ਨਰਵ (ulnar nerve) ਉਤੇਜਿਤ ਹੋ ਰਿਹਾ ਹੈ।

ਜੇਕਰ ਤੁਹਾਡੀ ਕੋਹਣੀ ਵਿੱਚ ਭੂਤਕਾਲ ਵਿੱਚ ਕੋਈ ਚੋਟ ਲੱਗੀ ਸੀ, ਤਾਂ ਇਹ ਲੱਛਣ ਉਸ ਟਰੌਮਾ ਨਾਲ ਜੁੜੇ ਹੋ ਸਕਦੇ ਹਨ। ਹਾਲਾਂਕਿ, ਪ੍ਰਾਇਮਰੀ ਓਸਟੀਓਆਰਥਰਾਈਟਿਸ (primary osteoarthritis) ਬਿਨਾਂ ਕਿਸੇ ਖਾਸ ਚੋਟ ਦੇ ਵੀ ਵਿਕਸਿਤ ਹੋ ਸਕਦੀ ਹੈ। ਤੁਹਾਡਾ ਸਰਜਨ ਤੁਹਾਡੀ ਉਮਰ, ਘਸਾਅ ਦੀ ਗੰਭੀਰਤਾ, ਅਤੇ ਤੁਹਾਡੇ ਹੱਥ ਦੀਆਂ ਲੋੜਾਂ ਨੂੰ ਦੇਖਦੇ ਹੋਏ ਅਗਲੇ ਸਭ ਤੋਂ ਵਧੀਆ ਰਸਤੇ ਦਾ ਫੈਸਲਾ ਕਰੇਗਾ। ਬਹੁਤ ਸਾਰੇ ਲੋਕਾਂ ਲਈ, ਗੈਰ-ਸਰਜਰੀਕ ਇਲਾਜ਼ ਸ਼ੁਰੂਆਤੀ ਪੜਾਅ ਵਿੱਚ ਇਹਨਾਂ ਲੱਛਣਾਂ ਨੂੰ ਪ੍ਰਬੰਧਿਤ ਕਰਨ ਲਈ ਪਹਿਲਾ ਕਦਮ ਹੁੰਦੇ ਹਨ।

ਅਸਲ ਵਿੱਚ ਕੀ ਹੋ ਰਿਹਾ ਹੈ

ਤੁਹਾਡਾ ਕੋਹਣੀ ਦਾ ਜੋੜ ਉੱਪਰਲੀ ਬਾਹ ਦੀ ਹੱਡੀ ਅਤੇ ਹੇਠਲੀ ਬਾਹ ਦੀਆਂ ਹੱਡੀਆਂ ਦੇ ਮਿਲਣ ਦੀ ਥਾਂ ਹੈ। ਆਸਟੀਓਆਰਥਰਾਈਟਿਸ ਵਿੱਚ, ਇਹਨਾਂ ਹੱਡੀਆਂ ਨੂੰ ਢੱਕਣ ਵਾਲੀ ਸਮੋਥ ਕਾਰਟੀਲੇਜ਼ ਖਰਾਬ ਹੋ ਜਾਂਦੀ ਹੈ। ਇਹ ਖਰਾਬ ਹੋਣ ਦੀ ਪ੍ਰਕਿਰਿਆ ਅਕਸਰ ਯੂਲੋਹਿਊਮੇਰਲ ਕੰਪਾਰਟਮੈਂਟ ਵਿੱਚ ਸ਼ੁਰੂ ਹੁੰਦੀ ਹੈ, ਜੋ ਤੁਹਾਡੀ ਕੋਹਣੀ ਦਾ ਮੁੱਖ ਹਿੰਜ ਹਿੱਸਾ ਹੈ। ਤੁਸੀਂ ਰੇਡੀਓਕੈਪਿਟੈਲਰ ਖੇਤਰ ਵਿੱਚ ਸਿਮਟਣ ਨੂੰ ਵੀ ਮਹਿਸੂਸ ਕਰ ਸਕਦੇ ਹੋ, ਜਿੱਥੇ ਬਾਹ ਦੀਆਂ ਹੱਡੀਆਂ ਕੋਹਣੀ ਦੇ ਜੋੜ ਦੇ ਨੇੜੇ ਮਿਲਦੀਆਂ ਹਨ।

ਜੋੜ ਵਿੱਚ ਬਦਲਾਅ ਆਉਣ ਨਾਲ, ਤੁਹਾਡਾ ਸਰੀਰ ਆਪਣੇ ਆਪ ਨੂੰ ਠੀਕ ਕਰਨ ਦੀ ਕੋਸ਼ਿਸ਼ ਕਰਦਾ ਹੈ ਅਤੇ ਵਾਧੂ ਹੱਡੀਆਂ ਵਧਾਉਂਦਾ ਹੈ। ਇਹਨਾਂ ਹੱਡੀਆਂ ਦੇ ਵਾਧੇ, ਜਿਨ੍ਹਾਂ ਨੂੰ ਆਸਟੀਓਫਾਈਟਸ ਕਿਹਾ ਜਾਂਦਾ ਹੈ, ਤੁਹਾਡੀਆਂ ਹੱਡੀਆਂ ਦੇ ਸਿਰਿਆਂ 'ਤੇ ਟੁੱਬੇ ਬਣਾ ਸਕਦੇ ਹਨ। ਜਦੋਂ ਤੁਸੀਂ ਆਪਣੀ ਬਾਹ ਨੂੰ ਸਿੱਧਾ ਕਰਦੇ ਹੋ, ਤਾਂ ਇਹ ਟੁੱਬੇ ਆਪਸ ਵਿੱਚ ਟਕਰਾ ਸਕਦੇ ਹਨ। ਇਹ ਇੱਕ ਭੌਤਿਕ ਰੁਕਾਵਟ ਪੈਦਾ ਕਰਦਾ ਹੈ ਜੋ ਤੁਹਾਨੂੰ ਕੋਹਣੀ ਨੂੰ ਪੂਰੀ ਤਰ੍ਹਾਂ ਸਿੱਧਾ ਕਰਨ ਤੋਂ ਰੋਕਦਾ ਹੈ। ਇਹੀ ਮਕੈਨੀਕਲ ਦਖਲਅੰਦਾਜ਼ੀ ਰੋਜ਼ਾਨਾ ਗਤੀਵਿਧੀਆਂ ਦੌਰਾਨ ਤੁਹਾਨੂੰ ਮਹਿਸੂਸ ਹੋਣ ਵਾਲੀ ਸਖ਼ਤੀ ਅਤੇ ਦਰਦ ਦਾ ਕਾਰਨ ਬਣਦੀ ਹੈ।

ਤੁਹਾਡੀ ਕੋਹਣੀ ਦੀ ਸਥਿਰਤਾ ਲਿਗਾਮੈਂਟਸ 'ਤੇ ਨਿਰਭਰ ਕਰਦੀ ਹੈ, ਜੋ ਕਿ ਹੱਡੀਆਂ ਨੂੰ ਇਕੱਠੇ ਰੱਖਣ ਵਾਲੀਆਂ ਰੱਸੀਆਂ ਵਾਂਗ ਕੰਮ ਕਰਨ ਵਾਲੀਆਂ ਮਜ਼ਬੂਤ ਟਿਸ਼ੂਆਂ ਦੀਆਂ ਪੱਟੀਆਂ ਹਨ। ਜੇਕਰ ਇਹ ਲਿਗਾਮੈਂਟਸ ਕਮਜ਼ੋਰ ਜਾਂ ਨੁਕਸਾਨੀ ਹੋ ਜਾਂਦੀਆਂ ਹਨ, ਤਾਂ ਹੱਡੀਆਂ ਆਪਣੀ ਥਾਂ ਤੋਂ ਹਿੱਲ ਸਕਦੀਆਂ ਹਨ। ਇਹ ਅਸਥਿਰਤਾ ਜੋੜ ਦੇ ਖਾਸ ਹਿੱਸਿਆਂ 'ਤੇ ਦਬਾਅ ਵਧਾਉਂਦੀ ਹੈ, ਜਿਸ ਨਾਲ ਖਰਾਬ ਹੋਣ ਦੀ ਪ੍ਰਕਿਰਿਆ ਤੇਜ਼ ਹੋ ਜਾਂਦੀ ਹੈ। ਸਮੇਂ ਦੇ ਨਾਲ, ਅਸਥਿਰਤਾ ਅਤੇ ਰਗੜ ਦਾ ਇਹ ਚੱਕਰ ਜੋੜ ਦੀਆਂ ਸਤਹਾਂ ਵਿੱਚ ਹੋਰ ਖ਼ਰਾਬੀ ਦਾ ਕਾਰਨ ਬਣਦਾ ਹੈ।

ਕੁਝ ਮਾਮਲਿਆਂ ਵਿੱਚ, ਚੋਟ ਜਾਂ ਸਰਜਰੀ ਤੋਂ ਬਾਅਦ, ਤੁਹਾਡਾ ਸਰੀਰ ਜੋੜ ਦੇ ਆਲੇ-ਦੁਆਲੇ ਦੇ ਨਰਮ ਟਿਸ਼ੂਆਂ ਵਿੱਚ ਹੱਡੀ ਬਣਾ ਸਕਦਾ ਹੈ। ਇਸਨੂੰ ਹੈਟਰੋਟੋਪਿਕ ਔਸਟੀਫਿਕੇਸ਼ਨ ਕਿਹਾ ਜਾਂਦਾ ਹੈ। ਇਹ ਇੱਕ ਸਖ਼ਤ ਰੁਕਾਵਟ ਪੈਦਾ ਕਰ ਸਕਦਾ ਹੈ ਜੋ ਤੁਹਾਡੀ ਗਤੀਵਿਧੀ ਨੂੰ ਸੀਮਿਤ ਕਰਦਾ ਹੈ, ਜਿਸ ਨਾਲ ਆਰਥਰਾਈਟਿਸ ਦੁਆਰਾ ਪੈਦਾ ਕੀਤੀ ਗਈ ਸਖ਼ਤੀ ਵਿੱਚ ਹੋਰ ਵਾਧਾ ਹੁੰਦਾ ਹੈ। ਇਹਨਾਂ ਬਦਲਾਵਾਂ ਨੂੰ ਸਮਝਣਾ ਇਸ ਗੱਲ ਦੀ ਵਿਆਖਿਆ ਕਰਨ ਵਿੱਚ ਮਦਦ ਕਰਦਾ ਹੈ ਕਿ ਸਧਾਰਨ ਆਰਾਮ ਅਕਸਰ ਕਾਫ਼ੀ ਨਹੀਂ ਹੁੰਦਾ ਅਤੇ ਕਾਰਜਸ਼ੀਲਤਾ ਨੂੰ ਬਹਾਲ ਕਰਨ ਲਈ ਟੀਚੇਬੱਧ ਇਲਾਜ ਦੀ ਲੋੜ ਕਿਉਂ ਹੁੰਦੀ ਹੈ।

ਇਸ ਬਾਰੇ ਅਸੀਂ ਕੀ ਕਰ ਸਕਦੇ ਹਾਂ

ਮੇਟਰ ਪ੍ਰਾਈਵੇਟ ਹਸਪਤਾਲ ਰੌਕਹੈਮਪਟਨ ਵਿੱਚ, ਡਾ. ਕੀਰਨ ਹਿਰਪਾਰਾ ਹੱਥੀਂ ਸੰਧੀ (elbow) ਦੇ ਆਸਟੀਓਆਰਥਰਾਈਟਸ ਨਾਲ ਇੱਕ ਕਦਮ-ਦਰ-ਕਦਮ ਯੋਜਨਾ ਰਾਹੀਂ ਸਰਗਰਮੀ ਨਾਲ ਸੰਬੰਧ ਰੱਖਦੇ ਹਨ ਜੋ ਤੁਹਾਡੀਆਂ ਰੋਜ਼ਾਨਾ ਲੋੜਾਂ ਨਾਲ ਮੇਲ ਖਾਂਦੀ ਹੈ। ਅਸੀਂ ਸਭ ਤੋਂ ਸਰਲ ਵਿਕਲਪਾਂ ਨਾਲ ਸ਼ੁਰੂਆਤ ਕਰਦੇ ਹਾਂ ਅਤੇ ਸਿਰਫ਼ ਤਦ ਹੀ ਸਰਜਰੀ ਵੱਲ ਵਧਦੇ ਹਾਂ ਜੇਕਰ ਤੁਹਾਨੂੰ ਵਧੇਰੇ ਰਾਹਤ ਦੀ ਲੋੜ ਹੋਵੇ। ਇਹ ਪ੍ਰਕਿਰਿਆ ਤੁਹਾਨੂੰ ਪਹਿਲਾਂ ਘੱਟ ਜੋਖਮ ਵਾਲੀ ਦੇਖਭਾਲ ਅਜ਼ਮਾਉਣ ਦੀ ਆਗਿਆ ਦਿੰਦੀ ਹੈ।

ਤੁਹਾਡਾ ਪਹਿਲਾ ਕਦਮ ਆਤਮ-ਪ੍ਰਬੰਧਨ ਅਤੇ ਭੌਤਿਕ ਚਿਕਿਤਸਾ (physiotherapy) ਹੈ। ਅਸੀਂ ਤੁਹਾਨੂੰ ਦਰਦਨਾਕ ਚਾਲਾਂ ਤੋਂ ਬਚਣ ਲਈ ਆਪਣੇ ਹੱਥੀਂ ਸੰਧੀ ਦੀ ਵਰਤੋਂ ਦੇ ਢੰਗ ਨੂੰ ਬਦਲਣ ਦੀ ਸਲਾਹ ਦਿੰਦੇ ਹਾਂ। ਇੱਕ ਭੌਤਿਕ ਚਿਕਿਤਸਕ ਜਾਂ ਹੱਥੀਂ ਸੰਧੀ ਥੈਰੇਪਿਸਟ ਤੁਹਾਨੂੰ ਹੱਥੀਂ ਸੰਧੀ ਨੂੰ ਸੁਚਾਰੂ ਢੰਗ ਨਾਲ ਚਲਾਈ ਰੱਖਣ ਲਈ ਹਲਕੀਆਂ ਵਰਕਆਊਟਾਂ ਸਿਖਾ ਸਕਦਾ ਹੈ। ਉਹ ਵਿਰਾਮ ਦੇ ਸਮੇਂ ਦੌਰਾਨ ਸੰਧੀ ਦਾ ਸਮਰਥਨ ਕਰਨ ਲਈ ਸਪਲਿੰਟਸ ਵੀ ਵਰਤ ਸਕਦੇ ਹਨ। ਇਸ ਪਹੁੰਚ ਨੂੰ ਕਈ ਹਫ਼ਤਿਆਂ ਲਈ ਇੱਕ ਨਿਆਂਯੁਕਤ ਅਜ਼ਮਾਇਸ਼ ਦਿਓ। ਕਈ ਲੋਕਾਂ ਨੂੰ ਪਤਾ ਚਲਦਾ ਹੈ ਕਿ ਗਤੀਵਿਧੀ ਵਿੱਚ ਬਦਲਾਅ ਅਤੇ ਨਿਰਦੇਸ਼ਿਤ ਵਰਕਆਊਟ ਘਸਾਈ-ਪਹਿਰਾਵਾ ਆਰਥਰਾਈਟਸ ਦੇ ਸ਼ੁਰੂਆਤੀ ਪੜਾਵਾਂ ਵਿੱਚ ਸਖ਼ਤੀ ਅਤੇ ਦਰਦ ਨੂੰ ਘਟਾਉਂਦੇ ਹਨ।

ਜੇਕਰ ਗਤੀ ਸਿਰਫ਼ ਕਾਫ਼ੀ ਨਹੀਂ ਹੈ, ਤਾਂ ਅਸੀਂ ਚਿਕਿਤਸਕ ਪ੍ਰਬੰਧਨ ਬਾਰੇ ਚਰਚਾ ਕਰਦੇ ਹਾਂ। ਇਸ ਵਿੱਚ ਦਰਦ ਨੂੰ ਘਟਾਉਣ ਵਾਲੀਆਂ ਦਵਾਈਆਂ ਅਤੇ ਸੋਜ ਨੂੰ ਸ਼ਾਂਤ ਕਰਨ ਵਾਲੀਆਂ ਐਂਟੀ-ਇਨਫਲੇਮੇਟਰੀ ਦਵਾਈਆਂ ਸ਼ਾਮਲ ਹਨ। ਅਸੀਂ ਸੰਧੀ ਵਿੱਚ ਇੰਜੈਕਸ਼ਨ ਵੀ ਦੇ ਸਕਦੇ ਹਾਂ। ਕੋਰਟੀਸੋਨ ਇੰਜੈਕਸ਼ਨ ਸੋਜ ਅਤੇ ਦਰਦ ਨੂੰ ਕੁਝ ਸਮੇਂ ਲਈ ਘਟਾ ਸਕਦੇ ਹਨ। ਹਿਆਲੂਰੋਨਿਕ ਐਸਿਡ ਜਾਂ ਪਲੇਟਲੈਟ-ਰਿਚ ਪਲਾਜ਼ਮਾ (PRP) ਇੰਜੈਕਸ਼ਨ ਦਾ ਉਦੇਸ਼ ਸੰਧੀ ਨੂੰ ਕੁਸ਼ਨ ਕਰਨਾ ਅਤੇ ਠੀਕ ਹੋਣ ਦੀ ਪ੍ਰਕਿਰਿਆ ਦਾ ਸਮਰਥਨ ਕਰਨਾ ਹੈ। ਇਹ ਇਲਾਜ ਆਰਥਰਾਈਟਸ ਦਾ ਇਲਾਜ ਨਹੀਂ ਕਰਦੇ, ਪਰ ਇਹ ਤੁਹਾਨੂੰ ਥੈਰੇਪੀ ਰਾਹੀਂ ਤਾਕਤ ਬਣਾਉਣ ਦੇ ਦੌਰਾਨ ਸਰਗਰਮ ਰਹਿਣ ਵਿੱਚ ਮਦਦ ਕਰ ਸਕਦੇ ਹਨ।

ਜਦੋਂ ਸੰਭਾਵੀ ਦੇਖਭਾਲ ਨੇ ਕਾਫ਼ੀ ਸੁਧਾਰ ਨਹੀਂ ਦਿੱਤਾ ਹੁੰਦਾ ਹੈ, ਤਾਂ ਸਰਜਰੀ 'ਤੇ ਵਿਚਾਰ ਕੀਤਾ ਜਾਂਦਾ ਹੈ। ਅਸੀਂ ਤੁਹਾਡੀ ਉਮਰ, ਘਸਾਈ ਦੀ ਗੰਭੀਰਤਾ ਅਤੇ ਤੁਹਾਡੇ ਹੱਥੀਂ ਸੰਧੀ ਨਾਲ ਕੀ ਕਰਨ ਦੀ ਲੋੜ ਹੈ, ਇਸ 'ਤੇ ਨਜ਼ਰ ਰੱਖਦੇ ਹਾਂ। ਜੇਕਰ ਤੁਹਾਡੇ ਕੋਲ ਹਲਕੇ ਤੋਂ ਮੱਧਮ ਆਰਥਰਾਈਟਸ ਹੈ, ਤਾਂ ਅਸੀਂ ਡਿਬ੍ਰਾਈਡਮੈਂਟ (debridement) ਨਾਮਕ ਇੱਕ ਪ੍ਰਕਿਰਿਆ ਦੀ ਸਿਫ਼ਾਰਿਸ਼ ਕਰ ਸਕਦੇ ਹਾਂ। ਇਸ ਵਿੱਚ ਗਤੀ ਨੂੰ ਬਿਹਤਰ ਬਣਾਉਣ ਅਤੇ ਦਰਦ ਨੂੰ ਘਟਾਉਣ ਲਈ ਹੱਡੀ ਦੇ ਸਪੂਰਸ ਅਤੇ ਢਿੱਲੀ ਟਿਸ਼ੂ ਨੂੰ ਸਾਫ਼ ਕਰਨਾ ਸ਼ਾਮਲ ਹੈ। ਉਨ੍ਹਾਂ ਗੰਭੀਰ ਮਾਮਲਿਆਂ ਵਿੱਚ ਜਿੱਥੇ ਸੰਧੀ ਬੁਰੀ ਤਰ੍ਹਾਂ ਨੁਕਸਾਨੀ ਗਈ ਹੈ, ਅਸੀਂ ਕੁੱਲ ਹੱਥੀਂ ਸੰਧੀ ਰੀਪਲੇਸਮੈਂਟ ਜਾਂ ਇੰਟਰਪੋਜ਼ਿਸ਼ਨ ਆਰਥਰੋਪਲਾਸਟੀ ਬਾਰੇ ਚਰਚਾ ਕਰਦੇ ਹਾਂ। ਇਹ ਵਿਕਲਪ ਕਾਰਜਕੁਸ਼ਲਤਾ ਨੂੰ ਪੁਨਰਸਥਾਪਿਤ ਕਰਨ ਲਈ ਸੰਧੀ ਦੀਆਂ ਸਤਹਾਂ ਨੂੰ ਬਦਲਦੇ ਜਾਂ ਦੁਬਾਰਾ ਸਤਹੀ ਬਣਾਉਂਦੇ ਹਨ। ਅਸੀਂ ਫ਼ੈਸਲਾ ਕਰਨ ਤੋਂ ਪਹਿਲਾਂ ਤੁਹਾਡੇ ਨਾਲ ਸਾਰੇ ਜੋਖਮਾਂ ਅਤੇ ਲਾਭਾਂ ਦੀ ਸਮੀਖਿਆ ਕਰਦੇ ਹਾਂ।

ਤੁਹਾਨੂੰ ਕੀ ਉਮੀਦ ਕਰਨੀ ਚਾਹੀਦੀ ਹੈ

ਤੁਹਾਡਾ ਕੋਹਣੀ ਦੇ ਘਸਾਅ ਅਤੇ ਘਸਣ ਵਾਲੇ ਆਰਥਰਾਈਟਸ ਨਾਲ ਸਫ਼ਰ ਆਮ ਤੌਰ 'ਤੇ ਗੈਰ-ਸਰਜਿਕਲ ਇਲਾਜ ਨਾਲ ਸ਼ੁਰੂ ਹੁੰਦਾ ਹੈ। ਇਹ ਸ਼ੁਰੂਆਤੀ ਲੱਛਣਾਂ ਲਈ ਮਿਆਰੀ ਪਹਿਲਾ ਕਦਮ ਹੈ। ਤੁਹਾਡਾ ਸਰਜਨ ਇਸ ਪਹੁੰਚ ਨੂੰ ਤੁਹਾਡੀ ਉਮਰ, ਘਸਾਅ ਦੀ ਗੰਭੀਰਤਾ ਅਤੇ ਤੁਹਾਡੀ ਬਾਹ ਨੂੰ ਕਿਹੜੀਆਂ ਗਤੀਵਿਧੀਆਂ ਕਰਨ ਦੀ ਲੋੜ ਹੈ, ਇਸ ਦੇ ਆਧਾਰ 'ਤੇ ਢਾਲੇਗਾ। ਬਹੁਤ ਸਾਰੇ ਲੋਕਾਂ ਲਈ, ਇਹ ਸੰਭਾਵੀ ਪ੍ਰਬੰਧਨ ਸ਼ੁਰੂਆਤੀ ਪੜਾਵਾਂ ਵਿੱਚ ਮਹੱਤਵਪੂਰਨ ਆਰਾਮ ਪ੍ਰਦਾਨ ਕਰਦਾ ਹੈ।

ਜੇਕਰ ਲੱਛਣ ਜਾਰੀ ਰਹਿੰਦੇ ਹਨ ਜਾਂ ਵਧਦੇ ਹਨ, ਤਾਂ ਸਰਜਿਕਲ ਵਿਕਲਪ ਗੱਲਬਾਤ ਦਾ ਹਿੱਸਾ ਬਣ ਜਾਂਦੇ ਹਨ। ਸਹੀ ਚੋਣ ਇਸ ਗੱਲ 'ਤੇ ਨਿਰਭਰ ਕਰਦੀ ਹੈ ਕਿ ਤੁਹਾਡਾ ਆਰਥਰਾਈਟਸ ਪਿਛਲੀ ਚੋਟ ਜਾਂ ਕੁਦਰਤੀ ਘਸਾਅ ਕਾਰਨ ਹੈ। ਹਲਕੇ ਤੋਂ ਮੱਧਮ ਮਾਮਲਿਆਂ ਲਈ, ਆਰਥਰੋਸਕੋਪਿਕ ਓਸਟੋਕੈਪਸੂਲਰ ਆਰਥਰੋਪਲਾਸਟੀ (ਹੱਡੀ ਦੇ ਸਪੂਰਸ ਨੂੰ ਸਾਫ਼ ਕਰਨਾ ਅਤੇ ਜੋੜ ਦੇ ਖੋਲ ਨੂੰ ਤੰਗ ਕਰਨਾ) ਇੱਕ ਸੁਰੱਖਿਅਤ ਅਤੇ ਪ੍ਰਭਾਵਸ਼ਾਲੀ ਵਿਕਲਪ ਹੈ। ਇਹ ਅਕਸਰ ਜਟਿਲਤਾਵਾਂ ਜਾਂ ਹੋਰ ਸਰਜਰੀ ਦੀ ਲੋੜ ਦੇ ਘੱਟ ਜੋਖਮ ਨਾਲ ਦਰਦ ਅਤੇ ਗਤੀ ਵਿੱਚ ਸੁਧਾਰ ਕਰਦਾ ਹੈ। ਉਹਨਾਂ ਲਈ ਜਿਨ੍ਹਾਂ ਨੂੰ ਇਸਦੀ ਲੋੜ ਹੈ, ਓਪਨ ਡਿਬ੍ਰਾਈਡਮੈਂਟ ਸਮਾਨ ਨਤੀਜੇ ਪ੍ਰਦਾਨ ਕਰਦਾ ਹੈ।

ਉਹਨਾਂ ਗੰਭੀਰ ਮਾਮਲਿਆਂ ਲਈ ਜਿੱਥੇ ਦਰਦ ਤੁਹਾਡੀ ਗਤੀ ਦੀ ਪੂਰੀ ਰੇਂਜ ਨੂੰ ਪ੍ਰਭਾਵਿਤ ਕਰਦਾ ਹੈ, ਜੋੜ ਦੀ ਤਬਦੀਲੀ (joint replacement) ਬਾਰੇ ਗੱਲ ਕੀਤੀ ਜਾ ਸਕਦੀ ਹੈ। ਕੁਦਰਤੀ ਆਰਥਰਾਈਟਸ ਲਈ ਕੁੱਲ ਕੋਹਣੀ ਦੀ ਤਬਦੀਲੀ (Total elbow replacement) ਇੱਕ ਵੈਧ ਵਿਕਲਪ ਹੈ, ਖਾਸ ਕਰਕੇ ਬੁੱਢੇ ਜਾਂ ਘੱਟ ਸਰਗਰਮ ਮਰੀਜ਼ਾਂ ਵਿੱਚ। ਹਾਲਾਂਕਿ, ਇਸਨੂੰ ਆਮ ਤੌਰ 'ਤੇ ਸਰਗਰਮ ਵਿਅਕਤੀਆਂ ਲਈ ਸਿਫਾਰਸ਼ ਨਹੀਂ ਕੀਤਾ ਜਾਂਦਾ ਕਿਉਂਕਿ ਇਸ ਵਿੱਚ ਜਟਿਲਤਾਵਾਂ ਦਾ ਦਰ ਜ਼ਿਆਦਾ ਹੁੰਦਾ ਹੈ ਅਤੇ ਇਸਦੀ ਟਿਕਾਊਪਨ ਸੀਮਿਤ ਹੁੰਦੀ ਹੈ। ਖਾਸ ਮਾਮਲਿਆਂ ਵਿੱਚ ਅੰਤਿਮ-ਪੜਾਅ ਦੇ ਪੋਸਟ-ਟਰੌਮੈਟਿਕ ਆਰਥਰਾਈਟਸ ਵਾਲੇ ਯੁਵਾ ਮਰੀਜ਼ਾਂ ਵਿੱਚ, ਸਥਿਰਤਾ ਨੂੰ ਬਹਾਲ ਕਰਨ ਲਈ ਅੰਸ਼ਕ ਤਬਦੀਲੀ ਜਾਂ ਲਿਗਾਮੈਂਟ ਮੁੜ-ਬਣਾਤ (ligament reconstruction) 'ਤੇ ਵਿਚਾਰ ਕੀਤਾ ਜਾ ਸਕਦਾ ਹੈ, ਹਾਲਾਂਕਿ ਇਹਨਾਂ ਵਿੱਚ ਰੀਵਿਜ਼ਨ ਦਰਾਂ ਜ਼ਿਆਦਾ ਹੁੰਦੀਆਂ ਹਨ।

ਬਹਾਲੀ ਤੁਹਾਡੇ ਦੁਆਰਾ ਚੁਣੇ ਰਾਹ 'ਤੇ ਨਿਰਭਰ ਕਰਦੇ ਹੋਏ ਵੱਖਰੀ ਮਹਿਸੂਸ ਹੁੰਦੀ ਹੈ। ਗੈਰ-ਸਰਜਿਕਲ ਇਲਾਜ ਨਾਲ, ਤੁਹਾਨੂੰ ਆਰਾਮ ਦੇ ਸਮੇਂ ਅਤੇ ਫਿਰ ਤੇਜ਼ੀ ਨਾਲ ਲੱਛਣਾਂ ਦੇ ਆਉਣ ਦੇ ਪੜਾਅ ਮਿਲ ਸਕਦੇ ਹਨ। ਆਰਥਰੋਸਕੋਪਿਕ ਡਿਬ੍ਰਾਈਡਮੈਂਟ ਨਾਲ, ਜ਼ਿਆਦਾਤਰ ਮਰੀਜ਼ਾਂ ਨੂੰ ਛੋਟੇ ਤੋਂ ਮੱਧਮ ਸਮੇਂ ਵਿੱਚ ਸੰਤੋਸ਼ਜਨਕ ਕਾਰਜਸ਼ੀਲਤਾ ਅਤੇ ਦਰਦ ਵਿੱਚ ਕਮੀ ਦੇ ਨਾਲ ਕੋਈ ਖਾਸ ਸਮੱਸਿਆ ਨਹੀਂ ਵਾਲੀ ਬਹਾਲੀ ਦਾ ਅਨੁਭਵ ਹੁੰਦਾ ਹੈ। ਹਾਲਾਂਕਿ ਛੋਟੇ ਅਤੇ ਮੱਧਮ ਸਮੇਂ ਦੇ ਫਾਲੋ-ਅਪ ਵਿਚਕਾਰ ਗਤੀ ਦੀ ਰੇਂਜ ਵਿੱਚ ਥੋੜ੍ਹੀ ਕਮੀ ਆ ਸਕਦੀ ਹੈ, ਪਰ ਕੁੱਲ ਨਤੀਜੇ ਅਨੁਕੂਲ ਰਹਿੰਦੇ ਹਨ। ਓਪਨ ਪ੍ਰੋਸੀਜ਼ਰ ਵੀ ਜ਼ਿਆਦਾਤਰ ਲਈ ਬਿਨਾਂ ਦਰਦ ਵਾਲੇ ਜੋੜ ਅਤੇ ਚੰਗੀ ਕਾਰਜਸ਼ੀਲ ਬਹਾਲੀ ਪ੍ਰਦਾਨ ਕਰਦੇ ਹਨ।

ਅੰਤ ਵਿੱਚ, ਜਦੋਂ ਇਲਾਜ ਤੁਹਾਡੀ ਖਾਸ ਸਥਿਤੀ ਨਾਲ ਮੇਲ ਖਾਂਦਾ ਹੈ, ਤਾਂ ਭਵਿੱਖਬਾਣੀ ਸਕਾਰਾਤਮਕ ਹੁੰਦੀ ਹੈ। ਭਾਵੇਂ ਤੁਸੀਂ ਸੰਭਾਵੀ ਉਪਾਵਾਂ ਨਾਲ ਸ਼ੁਰੂਆਤ ਕਰੋ ਜਾਂ ਸਰਜਰੀ ਵੱਲ ਵਧੋ, ਟੀਚਾ ਕਾਰਜਸ਼ੀਲਤਾ ਨੂੰ ਬਹਾਲ ਕਰਨਾ ਅਤੇ ਦਰਦ ਨੂੰ ਘਟਾਉਣਾ ਹੈ। ਤੁਹਾਡਾ ਸਰਜਨ ਤੁਹਾਨੂੰ ਇਹਨਾਂ ਚੋਣਾਂ ਰਾਹੀਂ ਮਾਰਗਦਰਸ਼ਨ ਕਰੇਗਾ, ਯਕੀਨੀ ਬਣਾਉਂਦੇ ਹੋਏ ਕਿ ਯੋਜਨਾ ਤੁਹਾਡੀ ਜੀਵਨ ਸ਼ੈਲੀ ਅਤੇ ਲੰਬੇ ਸਮੇਂ ਦੀ ਸਿਹਤ ਨਾਲ ਮੇਲ ਖਾਂਦੀ ਹੈ।

ਕਦੋਂ ਕਿਸੇ ਡਾਕਟਰ ਨੂੰ ਦਿਖਾਉਣਾ ਹੈ

ਜੇਕਰ ਤੁਹਾਡੇ ਨਾਲ ਛੋਟੀ ਉਮਰ ਦਾ ਕੋਹੜਾ ਦਰਦ ਹੈ ਜੋ ਆਰਾਮ ਨਾਲ ਨਹੀਂ ਸੁਧਰਦਾ, ਤਾਂ ਆਪਣੇ ਡਾਕਟਰ ਨੂੰ ਦਿਖਾਓ। ਜੇਕਰ ਤੁਹਾਨੂੰ ਕਮਜ਼ੋਰੀ, ਅਸਥਿਰਤਾ, ਜਾਂ ਬੰਦ ਹੋਣ ਦਾ ਅਹਿਸਾਸ ਹੁੰਦਾ ਹੈ, ਤਾਂ ਵਿਸ਼ੇਸ਼ਜ਼ ਦੀ ਸਮੀਖਿਆ ਲਈ ਕਹੋ। ਜੇਕਰ ਲੱਛਣ ਸੌਣ ਜਾਂ ਕੰਮ ਕਰਨ ਵਿੱਚ ਰੁਕਾਵਟ ਪਾਉਂਦੇ ਹਨ, ਤਾਂ ਇਹਨਾਂ ਦੀ ਧਿਆਨ ਨਾਲ ਜਾਂਚ ਕਰਨੀ ਚਾਹੀਦੀ ਹੈ। ਦਰਦ ਦਾ ਅਚਾਨਕ ਵਧਣਾ ਇਲਾਜ ਲੈਣ ਦਾ ਇੱਕ ਹੋਰ ਕਾਰਨ ਹੈ। ਪ੍ਰਾਇਮਰੀ ਕੋਹੜਾ ਆਸਟੀਓਆਰਥਰਾਈਟਸ ਅਕਸਰ ਦਰਦ ਅਤੇ ਗਤੀ ਵਿੱਚ ਕਮੀ ਨਾਲ ਪੇਸ਼ ਆਉਂਦਾ ਹੈ। ਇਹ ਮੁੱਖ ਤੌਰ 'ਤੇ ਉਨ੍ਹਾਂ ਵਿਚਕਾਰਲੀ ਉਮਰ ਦੇ ਪੁਰਸ਼ਾਂ ਨੂੰ ਪ੍ਰਭਾਵਿਤ ਕਰਦਾ ਹੈ ਜੋ ਭਾਰੀ ਮੈਨੁਅਲ ਕੰਮ ਕਰਦੇ ਹਨ। ਕੋਹੜੇ ਦੀ ਚੋਟ ਦਾ ਇਤਿਹਾਸ ਤੁਹਾਡੇ ਜੋਖਮ ਨੂੰ ਵਧਾਉਂਦਾ ਹੈ। ਵੱਧ ਉਮਰ ਅਤੇ ਪੁਰਸ਼ ਲਿੰਗ ਵੀ ਮਹੱਤਵਪੂਰਨ ਜੋਖਮ ਕਾਰਕ ਹਨ। ਅਸ਼ਸਤਰੀ ਇਲਾਜ ਸ਼ੁਰੂਆਤੀ ਪ੍ਰਬੰਧਨ ਵਿੱਚ ਪਹਿਲਾ ਕਦਮ ਹੈ। ਅਸ਼ਸਤਰੀ ਵਿਕਲਪ ਸ਼ੁਰੂਆਤੀ ਪੜਾਵਾਂ ਵਿੱਚ ਰਾਹਤ ਪ੍ਰਦਾਨ ਕਰ ਸਕਦੇ ਹਨ। ਤੁਹਾਡਾ ਸਰਜਨ ਤੁਹਾਡੀਆਂ ਖਾਸ ਲੋੜਾਂ ਅਨੁਸਾਰ ਇਲਾਜ ਨੂੰ ਢਾਲੇਗਾ।


Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

  • Nonoperative treatment remains the first step in the early management of elbow osteoarthritis [1].
  • Total elbow arthroplasty is a reliable treatment option for elbows severely affected by rheumatoid arthritis, with decreased prevalence of complications, maintenance of excellent pain relief, and functional restoration [17].
  • Total elbow arthroplasty is generally avoided in young, active patients due to poor durability [33].
  • Surgical options for severe elbow arthritis must be tailored to cartilage integrity and bone structure [33].
  • Open capsulectomy and debridement through a medial trans-flexor approach is associated with a low rate of complications and is safe and effective for the treatment of primary osteoarthritis of the elbow [2].
  • Elbow arthroscopic osteocapsular arthroplasty is a safe and efficacious treatment for patients with mild to moderate osteoarthritis [3].
  • Arthroscopic osteocapsular arthroplasty can be recommended for its favorable overall treatment outcomes for elbow osteoarthritis [25].
  • Arthroscopic debridement provides good short-term outcomes in primary elbow osteoarthritis and is associated with a low complication rate [4].
  • Arthroscopic debridement for primary degenerative osteoarthritis results in statistically significant and clinically relevant improvement in elbow range of motion and clinical outcomes with low complication and reoperation rates [14].
  • Computer simulation studies recommend arthroscopic debridement in the surgical management of patients with osteoarthritis of the elbow [6].
  • Both open elbow debridement and the Outerbridge-Kashiwagi (OK) procedure had excellent survivorship until conversion to total elbow arthroplasty and are viable options in the treatment of primary elbow osteoarthritis and post-traumatic cases [11].
  • The Outerbridge-Kashiwagi procedure is an effective and safe way of treating both posttraumatic arthritis and osteoarthritis of the elbow [12].
  • Open and arthroscopic debridement procedures are safe and effective in the treatment of elbow osteoarthritis [21].

Anatomy & Pathophysiology

  • Osteophytic change in primary elbow osteoarthritis occurs predominantly in the ulnohumeral compartment [45].
  • Joint space narrowing in primary elbow osteoarthritis more frequently affects the radiocapitellar articulation [45].
  • Three-dimensional computational models identify unique regions of bony impingement in elbow osteoarthritis, such as between the radial head and a posterior capitellar osteophyte in extension [35].
  • The combination of shoulder, elbow, and knee joint involvement accounts for approximately 70% of the contribution to all variables in the assessment of rheumatoid arthritis using the American College of Rheumatology Core Data Set [43].
  • The addition of wrist and ankle joints to the assessment of rheumatoid arthritis increases the contribution to all variables to approximately 90% [43].

Classification

  • The BM classification system demonstrated substantial intraobserver and interobserver reliability for evaluating radiographic severity of post-traumatic arthritis and primary osteoarthritis of the elbow [20].
  • The HR classification system demonstrated substantial intraobserver and interobserver reliability for evaluating radiographic severity of post-traumatic arthritis and primary osteoarthritis of the elbow [20].
  • The CT-based staging system for primary elbow osteoarthritis was highly reproducible and clinically feasible compared with previous plain radiograph-based staging systems [22].
  • The bony landmarks classification system effectively delineated osteophyte distribution in elbow osteoarthritis patients [36].
  • Both the Larsen and Sharp classifications can reliably be used to evaluate rheumatoid arthritis of the elbow by observers of varying training levels [42].

Clinical Presentation

  • Post-traumatic osteoarthritis of the elbow is an uncommon condition where clinical manifestations often vary from radiological findings [5].
  • Surgical treatment for elbow arthritis is based on disease etiology, severity of degeneration, and patient age [7].
  • The prevalence of primary elbow osteoarthritis in Japanese subjects aged 50-89 years was 25.2%, with most cases being asymptomatic [8].
  • The purpose of the review includes discussing the principles of diagnosis and evaluation for elbow arthritis [9].
  • Patients with either posttraumatic or primary degenerative osteoarthritis can expect satisfactory elbow function and an improvement in pain with little chance of reoperation at the midterm of the follow-up duration [10].
  • The appropriate treatment for elbow arthritis depends on the etiology, severity, patient age, and functional demands [13].
  • The medial approach is effective for the treatment of advanced primary osteoarthritis of the elbow, especially in patients with ulnar nerve symptoms as well as medial osteophytes [15].
  • Male patients with primary elbow osteoarthritis had cartilage loss predominantly in the radiocapitellar articulation [18].
  • Female patients with primary elbow osteoarthritis had similar radiocapitellar and ulnohumeral joint involvement, suggesting more symmetric cartilage wear [18].
  • The prevalence of elbow OA was 55.0% in respondents aged 40 years or older, with a symptomatic prevalence of 22.6% [23].
  • Older age, male sex, and a history of elbow trauma were identified as significant risk factors for elbow OA [23].
  • Treatment of elbow arthritis must be individualized based on etiology, severity, patient age, and functional demands [24].
  • Nonsurgical management may provide relief in early stages of elbow arthritis [24].
  • Surgical options for elbow arthritis range from arthroscopic debridement for pain at motion extremes to total elbow arthroplasty for pain throughout the arc of motion [24].
  • Primary osteoarthritis of the elbow is unique due to relative preservation of articular cartilage and maintenance of joint space with hypertrophic osteophyte formation [26].
  • Osteocapsular debridement is an effective surgical treatment option for patients with symptomatic primary elbow osteoarthritis who have failed conservative management [28].
  • When both the shoulder and elbow are involved, the joint that causes the most pain and disability should be operated on first [30].
  • Arthroscopic osteophyte resection and capsulectomy addresses the pathologic processes associated with arthritis of the elbow and was safe and effective [31].

Investigations

  • Male patients with primary elbow osteoarthritis had cartilage loss predominantly in the radiocapitellar articulation, while female patients had similar radiocapitellar and ulnohumeral joint involvement suggesting more symmetric cartilage wear [18].
  • Both the BM and HR classification systems demonstrated substantial intraobserver and interobserver reliability for evaluating radiographic severity of post-traumatic arthritis and primary osteoarthritis of the elbow [20].
  • CT-based staging system was highly reproducible and clinically feasible, compared with previous plain radiograph-based staging systems, for elbow osteoarthritis [22].
  • CT has greater sensitivity than radiographs for the detection of osteophytes and loose bodies in primary elbow osteoarthritis [49].

Treatment

  • Nonoperative treatment is the first step in the early management of elbow osteoarthritis [1].
  • Capsulectomy and debridement through a medial trans-flexor approach is associated with a low rate of complications and is safe and effective for the treatment of primary osteoarthritis of the elbow [2].
  • Elbow arthroscopic osteocapsular arthroplasty (AOA) is a safe, efficacious treatment for patients with mild to moderate osteoarthritis [3].
  • Arthroscopic treatment of elbow osteoarthritis provides good short-term outcomes in primary elbow osteoarthritis and is associated with a low complication rate [4].
  • Arthroscopic debridement is recommended in the surgical management of patients with osteoarthritis of the elbow based on computer simulation [6].
  • Both open elbow debridement and the Outerbridge-Kashiwagi (OK) procedure had excellent survivorship until conversion to total elbow arthroplasty [11].
  • Open elbow debridement and the OK procedure are viable options in the treatment of primary elbow osteoarthritis and post-traumatic cases [11].
  • The OK procedure is an effective and safe way of treating both posttraumatic arthritis and osteoarthritis of the elbow [12].
  • Elbow arthroscopic debridement for primary degenerative osteoarthritis results in statistically significant and clinically relevant improvement in elbow range of motion and clinical outcomes [14].
  • Elbow arthroscopic debridement for primary degenerative osteoarthritis is associated with low complication and reoperation rates [14].
  • Open and arthroscopic debridement procedures seem to be safe and effective in the treatment of elbow OA [21].
  • Arthroscopic treatment of elbow osteoarthritis significantly improved 6-month clinical results for functional scores, pain, strength and range of motion [38].
  • Surgical debridement is an effective treatment for the disabling symptoms of primary elbow OA with an acceptable complication rate [39].
  • Arthroscopic debridement for elbow osteoarthritis provides satisfactory pain relief, improvement of elbow motion, and good functional outcome [40].

Complications

  • Surgical treatment for elbow arthritis is associated with a low rate of complications when performed via a medial trans-flexor approach for capsulectomy and debridement in primary osteoarthritis [2].
  • Elbow arthroscopic osteocapsular arthroplasty (AOA) is considered a safe treatment for patients with mild to moderate osteoarthritis [3].
  • Arthroscopic treatment of elbow osteoarthritis is associated with a low complication rate [4].
  • Elbow arthroscopic debridement for primary degenerative osteoarthritis results in low complication and reoperation rates [14].
  • Total elbow arthroplasty remains associated with substantial complication and reoperation rates [37].

Recovery

  • Capsulectomy and debridement through a medial trans-flexor approach is associated with a low rate of complications and is safe and effective for primary osteoarthritis of the elbow [2].
  • Elbow arthroscopic osteocapsular arthroplasty (AOA) is a safe and efficacious treatment for patients with mild to moderate osteoarthritis [3].
  • Patients with either posttraumatic or primary degenerative osteoarthritis can expect satisfactory elbow function and an improvement in pain with little chance of reoperation at the midterm follow-up duration after arthroscopic elbow debridement [10].
  • Both open elbow debridement and the OK procedure have excellent survivorship until conversion to total elbow arthroplasty and are viable options for primary elbow osteoarthritis and post-traumatic cases [11].
  • Serial assessment of patients with primary elbow OA who underwent arthroscopic osteocapsular arthroplasty (OCA) showed that clinical outcomes improved from preoperative assessment to short- and medium-term follow-up [27].
  • Range of motion (ROM) decreased between short- and medium-term follow-up in patients with primary elbow OA who underwent arthroscopic OCA [27].
  • Most patients undergoing open debridement and radiocapitellar replacement in primary and post-traumatic arthritis of the elbow had an uneventful postoperative course, a painless elbow joint, and satisfactory functional recovery at short-term follow-up [32].
  • In most cases, elbow function was maintained in the long-term without loosening of the implant in patients with rheumatoid arthritis treated with Kudo type-5 total elbow arthroplasty [16].
  • Long-term follow-up showed acceptable results of the type-3 Kudo total elbow arthroplasty in patients with rheumatoid arthritis [29].
  • The outcome of GSB III total elbow arthroplasty in patients with rheumatoid arthritis tends to deteriorate over time because of loosening [44].
  • Total elbow arthroplasty restored satisfactory supportive range of motion to patients' elbow joints in the course of treatment for rheumatoid arthritis [51].

Key Evidence

  • [L5] Nonoperative treatment remains the first step in the early management of elbow osteoarthritis. [1] (10.2106/jbjs.e.00568)
  • [L4] This approach is associated with a low rate of complications and is safe and effective for the treatment of primary osteoarthritis of the elbow. [2] (10.1016/j.jhsa.2011.07.018)
  • [L4] Elbow AOA is a safe, efficacious treatment for patients with mild to moderate osteoarthritis. [3] (10.1016/j.jhsa.2015.11.018)
  • [L4] This minimally invasive technique provides good short-term outcomes in primary elbow osteoarthritis and is associated with a low complication rate. [4] (10.1016/j.otsr.2019.09.003)
  • [L4] Post-traumatic osteoarthritis of the elbow is an uncommon condition where clinical manifestations often vary from radiological findings. [5] (10.1016/j.otsr.2013.11.004)
  • [L4] The study recommends this technique in the surgical management of patients with osteoarthritis of the elbow. [6] (10.1302/0301-620x.96b2.30714)
  • [L5] Surgical treatment for elbow arthritis is based on disease etiology, severity of degeneration, and patient age. [7] (10.1016/j.jhsa.2007.12.022)
  • [L3] The prevalence of primary elbow osteoarthritis in Japanese subjects aged 50-89 years was 25.2%, with most cases being asymptomatic. [8] (10.1016/j.jse.2021.07.015)
  • [L5] The purpose of this article is to review the pertinent soft tissue and osseous anatomy, discuss the etiologies, review the principles of diagnosis and evaluation, and finally, study the treatment options for elbow arthritis. [9] (10.1016/j.jhsa.2022.12.014)
  • [L3] Patients with either pathology can expect satisfactory elbow function and an improvement in pain with little chance of reoperation at the midterm of the follow-up duration. [10] (10.1016/j.jseint.2021.07.018)
  • [L4] Both open elbow debridement and the OK procedure had excellent survivorship until conversion to total elbow arthroplasty and are viable options in the treatment of primary elbow osteoarthritis and post-traumatic cases. [11] (10.1016/j.jse.2022.01.138)
  • [L4] The OK procedure is an effective and safe way of treating both posttraumatic arthritis and osteoarthritis of the elbow. [12] (10.1016/j.jse.2015.11.052)
  • [L5] The appropriate treatment for elbow arthritis depends on the etiology, severity, patient age, and functional demands. [13] (10.1016/j.jhsa.2009.02.019)
  • [L1] Elbow arthroscopic debridement for primary degenerative osteoarthritis results in statistically significant and clinically relevant improvement in elbow range of motion and clinical outcomes with low complication and reoperation rates. [14] (10.1016/j.arthro.2017.08.247)
  • [L4] The medial approach is effective for the treatment of advanced primary osteoarthritis of the elbow, especially in patients with ulnar nerve symptoms as well as medial osteophytes. [15] (10.2106/jbjs.d.02684)
  • [L3] In most cases, elbow function was maintained in the long-term without loosening of the implant. [16] (10.1302/0301-620x.99b6.bjj-2016-1033.r2)
  • [L4] Total elbow arthroplasty has become a reliable treatment option for elbows severely affected by rheumatoid arthritis, with recent reports showing decreased prevalence of complications, maintenance of excellent pain relief, and functional restoration. [17] (10.2106/00004623-199805000-00008)
  • [L3] Male patients with primary elbow osteoarthritis had cartilage loss predominantly in the radiocapitellar articulation, while female patients had similar radiocapitellar and ulnohumeral joint involvement suggesting more symmetric cartilage wear. [18] (10.1177/17585732251327183)
  • [L3] Both the BM and HR classification systems demonstrated substantial intraobserver and interobserver reliability for evaluating radiographic severity of post-traumatic arthritis and primary osteoarthritis of the elbow. [20] (10.1016/j.jse.2014.10.015)
  • [L5] However, from the data we obtained the open and arthroscopic debridement procedures seem to be safe and effective in the treatment of elbow OA. [21] (10.1186/s12891-018-2318-x)
  • [L4] CT-based staging system was highly reproducible and clinically feasible, compared with previous plain radiograph-based staging systems, for elbow osteoarthritis. [22] (10.1016/j.joca.2019.03.004)
  • [L3] The prevalence of elbow OA was 55.0% in respondents aged 40 years or older, with a symptomatic prevalence of 22.6%; older age, male sex, and a history of elbow trauma were identified as significant risk factors. [23] (10.1016/j.jse.2018.02.049)
  • [L5] Treatment of elbow arthritis must be individualized based on etiology, severity, patient age, and functional demands; nonsurgical management may provide relief in early stages, while surgical options range from arthroscopic debridement for pain at motion extremes to total elbow arthroplasty for pain throughout the arc of motion. [24] (10.1016/j.jhsa.2012.12.037)
  • [L4] Arthroscopic osteocapsular arthroplasty can be recommended for its favorable overall treatment outcomes for elbow osteoarthritis. [25] (10.1016/j.jse.2019.09.036)
  • [L4] Primary osteoarthritis of the elbow is unique due to relative preservation of articular cartilage and maintenance of joint space with hypertrophic osteophyte formation. [26] (10.5435/00124635-200802000-00005)
  • [L4] Serial assessment of patients with primary elbow OA who underwent arthroscopic OCA showed that the clinical outcomes improved from preoperative assessment to short- and medium-term follow-up, although ROM decreased between short- and medium-term follow-up. [27] (10.1177/23259671231162398)
  • [L2] Osteocapsular debridement is an effective surgical treatment option for patients with symptomatic primary elbow osteoarthritis who have failed conservative management. [28] (10.1016/j.jse.2020.01.060)
  • [L3] This long-term follow-up study showed acceptable results of the type-3 Kudo total elbow arthroplasty in patients with rheumatoid arthritis. [29] (10.2106/00004623-200110000-00008)
  • [L4] When both the shoulder and elbow are involved, the joint that causes the most pain and disability should be operated on first. [30] (10.2106/00004623-198870010-00031)
  • [L4] This procedure addresses the pathologic processes associated with arthritis of the elbow and was safe and effective in this series. [31] (10.1016/j.jse.2007.04.005)
  • [L4] Most patients had an uneventful postoperative course and have shown a painless elbow joint, with satisfactory functional recovery at short-term follow-up. [32] (10.1016/j.jse.2011.08.071)
  • [L4] Surgical options must be tailored to cartilage integrity and bone structure, with total elbow arthroplasty generally avoided in young, active patients due to poor durability. [33] (10.1016/j.jhsg.2025.100736)
  • [L4] Three-dimensional computational models identified the locations and volumes of bony impingement in patients with osteoarthritis of the elbow and highlighted unique regions of impingement, such as between the radial head and a posterior capitellar osteophyte in extension. [35] (10.1016/j.jhsa.2013.03.035)
  • [L3] The bony landmarks classification system effectively delineated osteophyte distribution in elbow patients. [36] (10.1186/s13018-025-06145-9)
  • [L4] Total elbow arthroplasty remains associated with substantial complication and reoperation rates. [37] (10.1016/j.jhsg.2026.100981)
  • [L3] Arthroscopic treatment of elbow osteoarthritis significantly improved 6-month clinical results for functional scores, pain, strength and range of motion. [38] (10.1016/j.otsr.2019.09.002)
  • [L1] Surgical debridement is an effective treatment for the disabling symptoms of primary elbow OA with an acceptable complication rate. [39] (10.1302/2058-5241.5.190095)
  • [L4] Arthroscopic debridement for elbow osteoarthritis provides satisfactory pain relief, improvement of elbow motion, and good functional outcome. [40] (10.1016/j.jse.2014.01.009)
  • [L4] Both systems can reliably be used to evaluate rheumatoid arthritis of the elbow by observers of varying training levels. [42] (10.1016/j.jse.2016.07.074)
  • [L4] The combination of shoulder, elbow, and knee joints accounted for approximately 70% of the contribution to all the variables, while addition of the wrist and ankle joints increased this value to approximately 90%. [43] (10.1002/art.21589)
  • [L4] However, the outcome tends to deteriorate over time because of loosening, and further follow-up is required to analyze long-term loosening rates. [44] (10.1007/s10165-011-0509-5)
  • [L3] Osteophytic change occurs predominantly in the ulnohumeral compartment of the elbow, whereas joint space narrowing more frequently affects the radiocapitellar articulation. [45] (10.1016/j.jse.2006.08.005)
  • [L1] CT has greater sensitivity than radiographs for the detection of osteophytes and loose bodies in primary elbow osteoarthritis. [49] (10.1016/j.jse.2021.04.001)
  • [L4] In the course of total elbow arthroplasty, satisfactory supportive range of motion was restored to patients' elbow joints. [51] (10.1136/annrheumdis-2014-eular.2916)

References

[1] Management of Elbow Osteoarthritis. The Journal of Bone & Joint Surgery. 2006. DOI: 10.2106/jbjs.e.00568

[2] Capsulectomy and Debridement for Primary Osteoarthritis of the Elbow Through a Medial Trans-Flexor Approach. The Journal of Hand Surgery. 2011. DOI: 10.1016/j.jhsa.2011.07.018

[3] Outcomes of Elbow Arthroscopic Osteocapsular Arthroplasty. The Journal of Hand Surgery. 2016. DOI: 10.1016/j.jhsa.2015.11.018

[4] Arthroscopic treatment of elbow osteoarthritis. Orthopaedics & Traumatology: Surgery & Research. 2019. DOI: 10.1016/j.otsr.2019.09.003

[5] Post-traumatic osteoarthritis of the elbow. Orthopaedics & Traumatology: Surgery & Research. 2014. DOI: 10.1016/j.otsr.2013.11.004

[6] Arthroscopic debridement in the treatment of patients with osteoarthritis of the elbow, based on computer simulation. The Bone & Joint Journal. 2014. DOI: 10.1302/0301-620x.96b2.30714

[7] Surgical Options for the Arthritic Elbow. The Journal of Hand Surgery. 2008. DOI: 10.1016/j.jhsa.2007.12.022

[8] Prevalence and associated factors of primary elbow osteoarthritis in the Japanese general elderly population: a Japanese cohort survey randomly sampled from a basic resident registry. Journal of Shoulder and Elbow Surgery. 2022. DOI: 10.1016/j.jse.2021.07.015

[9] Elbow Arthritis. The Journal of Hand Surgery. 2023. DOI: 10.1016/j.jhsa.2022.12.014

[10] Midterm outcomes and survivorship of arthroscopic elbow debridement: a comparison of posttraumatic versus primary degenerative osteoarthritis. JSES International. 2022. DOI: 10.1016/j.jseint.2021.07.018

[11] Long-term survivorship of open débridement and débridement arthroplasty for elbow arthritis: a retrospective chart review. Journal of Shoulder and Elbow Surgery. 2022. DOI: 10.1016/j.jse.2022.01.138

[12] The outerbridge-kashiwagi procedure for primary degenerative arthritis of the elbow vs. post traumatic arthritis. Journal of Shoulder and Elbow Surgery. 2016. DOI: 10.1016/j.jse.2015.11.052

[13] Elbow Arthritis: Current Concepts. The Journal of Hand Surgery. 2009. DOI: 10.1016/j.jhsa.2009.02.019

[14] Arthroscopic Debridement for Primary Degenerative Osteoarthritis of the Elbow Leads to Significant Improvement in Range of Motion and Clinical Outcomes: A Systematic Review. Arthroscopy. 2017. DOI: 10.1016/j.arthro.2017.08.247

[15] Débridement Arthroplasty for Primary Osteoarthritis of the Elbow. Journal of Bone and Joint Surgery. 2005. DOI: 10.2106/jbjs.d.02684

[16] Kudo type-5 total elbow arthroplasty for patients with rheumatoid arthritis. The Bone & Joint Journal. 2017. DOI: 10.1302/0301-620x.99b6.bjj-2016-1033.r2

[17] Total Elbow Arthroplasty in Patients Who Have Juvenile Rheumatoid Arthritis. The Journal of Bone & Joint Surgery*. 1998. DOI: 10.2106/00004623-199805000-00008

[18] Sex-related differences in wear patterns in primary elbow osteoarthritis. Shoulder & Elbow. 2025. DOI: 10.1177/17585732251327183

[20] Reliability testing of two classification systems for osteoarthritis and post-traumatic arthritis of the elbow. Journal of Shoulder and Elbow Surgery. 2015. DOI: 10.1016/j.jse.2014.10.015

[21] Treatment of osteoarthritis of the elbow with open or arthroscopic debridement: a narrative review. BMC Musculoskeletal Disorders. 2018. DOI: 10.1186/s12891-018-2318-x

[22] Intraobserver and interobserver reliability of the computed tomography-based radiographic classification of primary elbow osteoarthritis: comparison with plain radiograph-based classification and clinical assessment. Osteoarthritis and Cartilage. 2019. DOI: 10.1016/j.joca.2019.03.004

[23] The prevalence of elbow osteoarthritis in Japanese middle-aged and elderly populations: the relationship between risk factors and function. Journal of Shoulder and Elbow Surgery. 2018. DOI: 10.1016/j.jse.2018.02.049

[24] Elbow Arthritis: Current Concepts. The Journal of Hand Surgery. 2013. DOI: 10.1016/j.jhsa.2012.12.037

[25] Arthroscopic osteocapsular arthroplasty for advanced-stage primary osteoarthritis of the elbow using a computed tomography–based classification. Journal of Shoulder and Elbow Surgery. 2020. DOI: 10.1016/j.jse.2019.09.036

[26] Primary Osteoarthritis of the Elbow: Current Treatment Options. Journal of the American Academy of Orthopaedic Surgeons. 2008. DOI: 10.5435/00124635-200802000-00005

[27] Serial Changes in Clinical Outcomes After Arthroscopic Osteocapsular Arthroplasty for Primary Elbow Osteoarthritis: A Medium-term Follow-up Study. Orthopaedic Journal of Sports Medicine. 2023. DOI: 10.1177/23259671231162398

[28] The Clinical Impact of Different Approaches to Osteocapsular Debridement for Primary Osteoarthritis of the Elbow: A Systematic Review. Journal of Shoulder and Elbow Surgery. 2020. DOI: 10.1016/j.jse.2020.01.060

[29] Kudo Total Elbow Arthroplasty in Patients with Rheumatoid Arthritis. The Journal of Bone and Joint Surgery-American Volume. 2001. DOI: 10.2106/00004623-200110000-00008

[30] Arthroplasty of the ipsilateral shoulder and elbow in patients who have rheumatoid arthritis.. The Journal of Bone & Joint Surgery. 1988. DOI: 10.2106/00004623-198870010-00031

[31] Osteoarthritis of the elbow: Results of arthroscopic osteophyte resection and capsulectomy. Journal of Shoulder and Elbow Surgery. 2008. DOI: 10.1016/j.jse.2007.04.005

[32] Open debridement and radiocapitellar replacement in primary and post-traumatic arthritis of the elbow: a multicenter study. Journal of Shoulder and Elbow Surgery. 2012. DOI: 10.1016/j.jse.2011.08.071

[33] Management of Severe Elbow Arthritis in a Young Patient. Journal of Hand Surgery Global Online. 2025. DOI: 10.1016/j.jhsg.2025.100736

[35] Identifying the Location and Volume of Bony Impingement in Elbow Osteoarthritis by 3-Dimensional Computational Modeling. The Journal of Hand Surgery. 2013. DOI: 10.1016/j.jhsa.2013.03.035

[36] Bony landmarks guided mapping of the osteophytes of the elbow osteoarthritis patients: a three dimensional computed tomograph based study. Journal of Orthopaedic Surgery and Research. 2025. DOI: 10.1186/s13018-025-06145-9

[37] Total Elbow Arthroplasty Complication, Reoperation, and Revision Rates: A Comparison Between Arthroplasty for Arthritis Versus Fracture. Journal of Hand Surgery Global Online. 2026. DOI: 10.1016/j.jhsg.2026.100981

[38] Arthroscopic debridement for osteoarthritis of the elbow: Results and analysis of predictive factors. Orthopaedics & Traumatology: Surgery & Research. 2019. DOI: 10.1016/j.otsr.2019.09.002

[39] Arthroscopic and open debridement in primary elbow osteoarthritis: a systematic review and meta-analysis. EFORT Open Reviews. 2020. DOI: 10.1302/2058-5241.5.190095

[40] Arthroscopic débridement for primary osteoarthritis of the elbow: analysis of preoperative factors affecting outcome. Journal of Shoulder and Elbow Surgery. 2014. DOI: 10.1016/j.jse.2014.01.009

[42] Reliability testing of the Larsen and Sharp classifications for rheumatoid arthritis of the elbow. Journal of Shoulder and Elbow Surgery. 2017. DOI: 10.1016/j.jse.2016.07.074

[43] Impact of shoulder, elbow, and knee joint involvement on assessment of rheumatoid arthritis using the American College of Rheumatology Core Data Set. Arthritis Care & Research. 2005. DOI: 10.1002/art.21589

[44] Clinical and radiological results of GSB III total elbow arthroplasty in patients with rheumatoid arthritis. Modern Rheumatology. 2011. DOI: 10.1007/s10165-011-0509-5

[45] Radiographic changes at the elbow in primary osteoarthritis: A comparison with normal aging of the elbow joint. Journal of Shoulder and Elbow Surgery. 2007. DOI: 10.1016/j.jse.2006.08.005

[49] Effectiveness of radiographs and computed tomography in evaluating primary elbow osteoarthritis. Journal of Shoulder and Elbow Surgery. 2021. DOI: 10.1016/j.jse.2021.04.001

[51] AB0306 Does Total Elbow Arthroplasty Improve Disease Activity Scores and HAQ in Patients with Rheumatoid Arthritis Treated with Biologics?. Annals of the Rheumatic Diseases. 2014. DOI: 10.1136/annrheumdis-2014-eular.2916

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.